| 1 |
dpavlin |
1.1 |
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN"> |
| 2 |
|
|
<html> |
| 3 |
|
|
<head> |
| 4 |
|
|
<title></title> |
| 5 |
|
|
<meta http-equiv="content-type" content="text/html; charset=ISO-8859-1"> |
| 6 |
|
|
</head> |
| 7 |
|
|
<body> |
| 8 |
|
|
<div align="Center"><b>State-of-the-art facility<br> |
| 9 |
|
|
<br> |
| 10 |
|
|
</b> |
| 11 |
|
|
<div align="Left"><i>Zagreb, 12 December 2001</i><br> |
| 12 |
|
|
<br> |
| 13 |
|
|
<div align="Center">Croatian Prime Minister Ivica Racan opens PLIVA’s new |
| 14 |
|
|
Oral Solid Dosage Forms facility<br> |
| 15 |
|
|
</div> |
| 16 |
|
|
</div> |
| 17 |
|
|
<br> |
| 18 |
|
|
</div> |
| 19 |
|
|
With the press of a button, Croatian Prime Minister Ivica Racan launched |
| 20 |
|
|
the automatically controlled vehicle, symbolically opening PLIVA’s new Oral |
| 21 |
|
|
Solid Dosage Forms facility, one of the state-of-the-art facilities for the |
| 22 |
|
|
production of oral solid drug forms in the world. Accompanying Prime Minister |
| 23 |
|
|
Racan were Croatian Minister of Health Andro Vlahucic, representatives from |
| 24 |
|
|
the Croatian Institute for Drug Control, the Croatian Institute for Health |
| 25 |
|
|
Insurance (HZZO), Faculty of Medicine and Faculty of Pharmacy and Biochemistry, |
| 26 |
|
|
whose hosts from PLIVA were CEO of PLIVA Zeljko Covic, members of PLIVA’s |
| 27 |
|
|
Management Board and the Oral Solid Dosage Forms Facility Project Director |
| 28 |
|
|
Zeljko Brebric. <br> |
| 29 |
|
|
<br> |
| 30 |
|
|
The total investment amounted approximately to HRK 640 million, which ranks |
| 31 |
|
|
PLIVA among the largest investors in Croatian economy, and the entire project, |
| 32 |
|
|
from the project beginning to full operation, lasted about three years.<br> |
| 33 |
|
|
<br> |
| 34 |
|
|
The plant was constructed in line with the highest international standards |
| 35 |
|
|
and is one of the most modern facilities in the world. Highly sophisticated |
| 36 |
|
|
equipment and level of automatization will significantly shorten the manufacturing |
| 37 |
|
|
process, enable the production of a range of various products and reduce |
| 38 |
|
|
production costs. The facility will manufacture more than 900 tons, or approximately |
| 39 |
|
|
2 billion tablets, coated tablets and capsules.<br> |
| 40 |
|
|
<br> |
| 41 |
|
|
The basic features of the new facility are automated transport of bulk substances, |
| 42 |
|
|
intermediaries and finished products as well as closed production areas completely |
| 43 |
|
|
aligned with the most demanding sanitary requirements, production conditions |
| 44 |
|
|
and personnel safety requirements. Seventy specially trained employees will |
| 45 |
|
|
be working in the new Oral Solid Dosage Forms facility. <br> |
| 46 |
|
|
<br> |
| 47 |
|
|
Part of the investment is the completely automated high-reach warehouse for |
| 48 |
|
|
starting material and intermediaries; a “pilot” plant where new drugs from |
| 49 |
|
|
PLIVA’s Development can be effectively reproduced in larger - semiindustrial |
| 50 |
|
|
amounts, at the same time ensuring the equal level of quality, enabling them |
| 51 |
|
|
to enter industrial manufacturing as such. In addition, the drug packaging |
| 52 |
|
|
plant has been completely renovated, new modern analytical laboratories have |
| 53 |
|
|
been built as well as a management and administration center and measurement |
| 54 |
|
|
and calibration center. <br> |
| 55 |
|
|
<br> |
| 56 |
|
|
The construction of PLIVA’s new facility lasted three years. The technological |
| 57 |
|
|
project was designed in cooperation with the Belgian consultant ELVECO, facility |
| 58 |
|
|
design and installation were performed by the Croatian company “Termoinzenjering” |
| 59 |
|
|
and construction was carried out by “Tehnika”. The general contractor for |
| 60 |
|
|
interior work and technical infrastructure was the Austrian company VATECH |
| 61 |
|
|
Elin EBG, whose most important subcontractors were the Croatian companies |
| 62 |
|
|
Ekomont, Enel, Termovod, Siemens-Landis&Staefa, Enikon, Tehnomobil, Tehnika |
| 63 |
|
|
and others. During the design and construction, PLIVA placed special attention |
| 64 |
|
|
on environmental protection issues. Production has no affects on the environment, |
| 65 |
|
|
and all waste resulting from production is treated according to the highest |
| 66 |
|
|
international environmental standards.<br> |
| 67 |
|
|
<br> |
| 68 |
|
|
Commenting on the significance of this facility for PLIVA’s operations in |
| 69 |
|
|
the future, PLIVA’s CEO Zeljko Covic stressed: “Owing to the fact that it |
| 70 |
|
|
meets the highest standards of Good Manufacturing Practice, the most important |
| 71 |
|
|
feature of this new facility is that it will enable the production of finished |
| 72 |
|
|
drug forms to be exported to the demanding West European and US markets. |
| 73 |
|
|
With the construction of the new Oral Solid Dosage Forms facility, PLIVA |
| 74 |
|
|
has met the demands of the market that requires a wide range of high quality |
| 75 |
|
|
pharmaceutical products, with the highest standards of safety at work, environmental |
| 76 |
|
|
protection and energy management. This fulfills PLIVA’s vision – to be a |
| 77 |
|
|
pharmaceutical company bringing superior and innovative solutions to customer |
| 78 |
|
|
needs, by competing in the global market.”<br> |
| 79 |
|
|
</body> |
| 80 |
|
|
</html> |
Parent Directory
| 
Revision Log